X

Bliss GVS Pharma Ltd. Stock Analysis

Small Cap
Evaluated by 1083 users | BSE: 506197 | NSE: BLISSGVS |
Pharmaceuticals & Drugs
Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Bliss GVS Pharma Ltd. has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 26.29%23.66%19.86%12.44%13.96%13.42%12.18%9.65%8.78%10.56%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 219267354288313326348298427442
Y-o-Y Gr. Rt.-22%32.4%-18.5%8.6%4.3%6.6%-14.4%43.2%3.6%
Adjusted EPS (Rs.) 3.884.224.863.85.055.45.775.155.377.1
Y-o-Y Gr. Rt.-8.8%15.2%-21.8%32.9%6.9%6.9%-10.8%4.3%32.2%
Book Value per Share (Rs.) 16.1520.424.8530.3935.6541.8947.6652.4958.4966.21
Adjusted Net Profit 4043.550.239.252.155.759.553.255.373.2
Net Op. Cash Flow (Rs. Cr.) 23.768.7-51.964.715.459.638.522.748.358
Debt to Cash Flow from Ops 0.350.09-1.461.335.851.361.964.141.481.52
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Bliss GVS Pharma Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 8.1%7.1%8.3%3.6%
Adjusted EPS 6.9%7.1%7.2%32.2%
Book Value per Share 1713.211.613.2
Share Price 23.2% -3% -4.8% 14.3%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 26.6823.0721.3813.6515.2613.9212.8810.299.6711.38
Operating Profit Margin (%) 26.8426.8428.5222.9227.5529.5929.0229.722.3822.66
Net Profit Margin (%) 18.2816.2914.1813.5816.6517.0617.0917.8512.9716.56
Debt to Equity 0.050.030.30.280.240.190.150.170.120.13
Working Capital Days 239231270508497527533621442443
Cash Conversion Cycle 147118100144154206206270269306
Entity Percentage Holding
Promoters 41.60%
Institutions 29.10%
Non-Institutions 29.31%
Pledged *0.000.000.000.000.000.000.000.000.000.33
* Pledged shares as % of Promoter's holding (%)

MoneyWorks4Me analysed the past 10-year performance of Bliss GVS Pharma Ltd. and arrived at the following conclusion:

Past 10 year's financial track record indicates that Bliss GVS Pharma Ltd. is a average quality company. However, for specific investment actions please connect with your investment advisor.

The 5-year analysis of Bliss GVS Pharma Ltd.'s performance infers:

Bliss GVS Pharma Ltd. earnings have grown by 7.1%, whereas share price has depreciated -3% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Bliss GVS Pharma Ltd. share prices over the last 10 years. Here is what we found out:

Bliss GVS Pharma Ltd. share price has depreciated 15.9% annually over the past ten years.

Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for

Bliss Gvs Pharma Limited was incorporated on December 11, 1984, as Public Limited Company. It is listed on Bombay and Delhi Stock Exchange. The company’s most unique product is ‘Today Vaginal Contraceptive’, a safe female contraceptive aimed at furthering Planned Parenthood and is also an established method for preventing conception. Bliss also manufactures to US specification vaginal pessaries of Clotrimazole & Povidone Iodine in addition to Anal Suppositories for treatment of piles.

The company also manufacture wide range of Pessary Formulations, Suppository Formulations, Calcium Preparation, Protein Powders, Iron Preparation, Antibiotics, Analgesic & Antipyretics, Respiratory, Anti-inflammatory, Dermatological Preparations, Anti-Diarrhoeal products.

It has a sophisticated automatic plant situated at Palghar (approx. 90 km from Mumbai) in an Industrial area which is well-developed with all Infra-structural facilities. This site is around 1.5 km away from Palghar Railway Station on the Western Railway and is well-connected by road and rail to most parts of the country, including Mumbai.

The plant aims to be as the most modern and one of its kind in the Indian sub-continent, to manufacture suppositories. Complete overhaul and annual maintenance has kept the plant in excellent condition and fully operational with minimum down time. Spares and consumables are maintained at proper levels to prevent unnecessary delays and the company has made efforts to employ a qualified Maintenance Engineer since production should not be hampered in any way.

Product range

The Prescription drugs of the company include Antimalarial- Alaxin, Gvither, P-Alaxin, Gsunate and  Lonart   

Anal Suppositories - Rectol, Poroxicam, Parafen, Vomitin, Slipizem, AnomexProchloperazine, Conlax, Xtacy, Meloxicam, Rectcin and Glycerin

Vaginal Pessaries - Imazole, Gvgyl, Terconazole, Vagid, Gvgyl - N, ClindemycinPovid / Gevid, Blissfast / Gynanfort, Klovinal, Micozole, Blissnox / Wellgynax, Ecozole and Vagikit   

General-Lofnac, Comit, Zinvite, Funbact-A, Aceclofenac, Gudapet, Gvfluc, Clamoxin, Gbactin and Alvite       

Its over the counter products are:

Today contraceptive, available in different types- Today Regular, Today Economy, Today Premium.Maitri Vaginal Lubricant Pessary- PEG-1500, PEG-1000, Fragrance.

Milestones

2010
• Commissioning of new State-of-Art Manufacturing Facility for Suppositories and Pessaries at Palghar.
• Entry into Middle East through Commissioning of Manufacturing Unit for Suppositories and Pessaries through Strategic Joint venture.
•  S N. Kamath, Promoter & Managing Director of the company has received a National Award -2009 from Government of India in recognition outstanding performance Entrepreneurship under Medium Enterprises.

2011
• EU-GMP approval for Suppositories and Pessaries manufacturing facility at Palghar.
• Entry into Russia and other CIS markets

2012
• Strategic Acquisition of Semi Solid Manufacturing unit to strengthen presence in dermatological segment.
• Expansion of product portfolio by setting-up manufacturing Unit for Dry Powder for Injection, Ampoules, Eye/ Ear/Nose Drops at Daman.

2013
• Expansion of Research and Development Centre and DSIR approval.
• Launch of strategic marketing unit for front-end integration.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback